No randomised trial of prostate-cancer screening in Norway

The Lancet Oncology
S D FossåNorwegian Urological Cancer Group

Abstract

The Norwegian Urological Cancer Group (NUCG) decided against participating in the European Randomised Study on Screening for Prostate Cancer, to which they had planned to contribute data from a population of 75 000 men aged between 50 and 65. The plan was abandonned for three main reasons: Norwegian doubts about the statistical power of the trial, the possible ethical implications of screening a large number of men with no symptoms, and the belief that the trial would not produce clinically important results. In this review, the NUCG's reasons for not participating in the trial are discussed in full.

References

Jun 15, 1982·International Journal of Cancer. Journal International Du Cancer·R YataniP Correa
Apr 16, 1994·Lancet·H O AdamiK J Rothman
Feb 1, 1993·The Australian & New Zealand Journal of Obstetrics & Gynaecology·B L Kneale, G G Giles
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C A Stiller
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Mar 21, 2002·The Lancet Oncology·S D FossåUNKNOWN Norwegian Urological Cancer Group
Mar 11, 2003·Prostate Cancer and Prostatic Diseases·L M EriL L Håheim

❮ Previous
Next ❯

Citations

Apr 20, 2004·Critical Reviews in Oncology/hematology·Hans-Peter SchmidLadislav Prikler
Apr 4, 2003·Lancet·Stephen FrankelDavid Neal
Jul 20, 2016·European Journal of Epidemiology·Morten ValbergOdd O Aalen
Mar 21, 2002·The Lancet Oncology·S D FossåUNKNOWN Norwegian Urological Cancer Group
Sep 11, 2007·European Urology·Richard J Bryant, Freddie C Hamdy
Feb 24, 2015·The Medical Clinics of North America·Michael C Soung
Jul 29, 2008·International Journal of Cancer. Journal International Du Cancer·Richard M MartinTom I L Nilsen
Nov 6, 2003·Scandinavian Journal of Clinical and Laboratory Investigation·I N NorderhaugO H Førde

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.